Design, synthesis and structure-activity relationship studies of a focused library of pyrimidine moiety with anti-proliferative and anti-metastasis activities in triple negative breast cancer-Reference-Cited by-同舟云学术

Design, synthesis and structure-activity relationship studies of a focused library of pyrimidine moiety with anti-proliferative and anti-metastasis activities in triple negative breast cancer

Published:2017-11 Issue: Volume:140 Page:155-171
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Yao Dahong,Zhou Yuxin,Zhu Lingjuan,Ouyang Liang,Zhang Jin,Jiang Yingnan,Zhao Yuqian,Sun Dejuan,Yang Shilin,Yu Yang,Wang Jinhui

Funder

National Key R&D Program of China

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference26 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J. Clin.,2015

2. Breast cancer targeted therapy: successes and challenges;The;Lancet,2017

3. What is triple-negative breast cancer?;Irvin;Eur. J. Cancer,2008

4. Triple-negative breast cancer: advancements in characterization and treatment approach;Hurvitz;Curr. Opin. Obstet. Gynecol.,2016

5. Integrative analysis of genomic alterations in triple-negative breast cancer in association with homologous recombination deficiency;Kawazu;PLoS Genet.,2017

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review of small molecules targeting PI3K pathway: Exploring the structural development for the treatment of breast cancer;Bioorganic Chemistry;2024-02

2. An insight into the biological activity and structure-based drug design attributes of sulfonylpiperazine derivatives;Journal of Molecular Structure;2023-04

3. Discovery of fused benzimidazole-imidazole autophagic flux inhibitors for treatment of triple-negative breast cancer;European Journal of Medicinal Chemistry;2022-10

4. Cancer targeted drug delivery using active low-density lipoprotein nanoparticles encapsulated pyrimidines heterocyclic anticancer agents as microtubule inhibitors;Drug Delivery;2022-08-26

5. Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies;Journal of Hematology & Oncology;2022-04-12